Prostate Cancer Canada

Research

For more information visit
www.movember.com

In The News

PSA Fitness (Power, Strength & Agility)
HALIFAX, N.S., January 16, 2012/CNW/ Prostate Cancer Canada Atlantic is proud to announce the launch of PSA Fitness (Power, Strength & Agility), a free nine week exercise program for men who have been diagnosed with prostate cancer. PSA Fitness, resistance training and yoga, is an important patient-centered therapy for prostate cancer survivors in Halifax.

TELUS donation to support Prostate Cancer Canada
Toronto, ON- January 13, 2012- On January 10th, Prostate Cancer Canada received a generous donation of $100,000 from TELUS at the launch of the TIEd Together exhibition. TELUS’ donation was made possible through the Canadian Football League Grey Cup cause marketing campaign. The donation will support Prostate Cancer Canada’s ongoing efforts to eliminate the disease through research, education, support and awareness.

Click For Information Archive

Clinician-Scientist Program

In the Spring of 2009, Prostate Cancer Canada offered a limited number of awards to provide salary and research support for outstanding Clinician-Scientists initiating a career as independent investigators/junior faculty in prostate cancer research. These awards provide the opportunity for new faculty with three or fewer years of service as independent investigators to develop and demonstrate independence in initiating and conducting prostate cancer research. Candidates for the Prostate Cancer Canada Clinician-Scientist award must:

hold an M.D. degree or equivalent;
be licensed to practice medicine in Canada; and
be nominated by a hospital-affiliated research institution.

Prostate Cancer Canada will make a maximum total contribution of $150,000 per year, per award, for up to two years

What does a Clinician-Scientist do?

Clinician-Scientists are essentially scientists who are clinically trained and may do a small amount of clinical work, but their core focus is research in their given discipline (e.g. medical oncology, radiation, uro-oncology etc.) Clinician-Scientists have a background that supports translation from basic science to clinical practice and they link closely with clinician researchers. These individuals not only require their clinical training, but usually have a PhD or equivalent additional training.

Clinician-Scientists make a major contribution in the translation of research knowledge into improved patient care and health. Their research flows from bench to bedside to community. They also translate advances in technology and fundamental understanding of disease processes to situations that are clinically faced on a daily basis. They ensure rapid knowledge translation across the continuum from discovery to application to policy. Clinician-Scientists are critical to this research process as they function between disciplines and encourage collaboration between basic science and clinical research communities. In today’s world of “evidence based” treatments, the clinician-scientist is ultimately required to gather the evidence.

2012 Request for Applications: Clinician-Scientist Program

1. Program Objective
This Request for Applications (RFA) is intended to support research for Clinician-Scientists initiating a career as an investigator/junior faculty in prostate cancer research.

2. Mechanisms of Support
The Clinician-Scientist Award has a length of 2 years and a value of $150,000/year

3. Program Eligibility
In order to apply for this award, applicants must:

have five years or less of service as an independent investigator within the area of prostate cancer research
possess an M.D. degree or equivalent
be licensed to practice medicine in Canada
be nominated by a hospital-affiliated research institution
candidates who are currently in training must start as faculty in July 2012 in order to be eligible to apply

4. Applications
To apply, applicants must fill out an online application form which will be found on the Prostate Cancer Canada website: Application.

5. Important Dates
Competition Opens January 3, 2012
Application Deadline March 15, 2012 at 5pm EST.
Notice of Decision June 29, 2012
Funding Start Date July 3, 2012

6. Contact

Susan Langlois

susan.langlois@prostatecancer.ca

Prostate Cancer Canada

2 Lombard Street, 3^rd Floor

Toronto, Ontario M5C 1M1

416-441-2131 Ext. 246

1-888-225-0333

susan.langlois@prostatecancer.ca